Health Service Executive (HSE) has awarded a €40M biochemistry services contract for UHW, SLK, TippUH and WGH to Roche Diagnostics Limited

Health Service Executive (HSE), a body governed by public law operating in the health sector, has awarded a contract for the provision of Biochemistry Services at University Hospital Waterford (UHW), St. Luke's General Hospital Kilkenny (SLK), Tipperary University Hospital (TippUH) and Wexford General Hospital (WGH) to Roche Diagnostics Limited. The awarded value of the contract is €40,000,000.00, covering hospital laboratory equipment and related proprietary consumables/services under Lot F, classified as spectroscopy devices. The contract was awarded following an open procedure under the standard regime, governed by EU Directive 2014/24/EU.

Introduction

Health Service Executive (HSE), a body governed by public law operating in the health sector, has conducted an open procedure for the provision of Biochemistry Services at University Hospital Waterford, St. Luke's General Hospital Kilkenny, Tipperary University Hospital and Wexford General Hospital. The requirement is described in the published Invitation to Tender (ITT). The procurement covers hospital laboratory equipment and related proprietary consumables/services under Lot F, with the main classification being spectroscopy devices (CPV 33114000) and a wide range of additional classifications covering diagnostic devices, diagnostic systems, reagent strips, incubators, diagnostic agents, reagents and contrast media, laboratory glassware, clinical forensics equipment and supplies, laboratory, optical and precision equipment, microscopes, PCR equipment, laboratory furniture, laboratory pumps, centrifuges, calibration services, laboratory services and veterinary services.

The procurement is not financed with EU funds but is covered by the Government Procurement Agreement (GPA). No strategic procurement objectives were specified. The evaluation criteria are quality (60%) and cost (40%). The estimated value and the awarded value are €40,000,000.00. Four tenders were submitted electronically, and one winner was appointed: Roche Diagnostics Limited (large enterprise). No subcontracting was declared. The contract was concluded on 04 August 2026.

Why This Contract Matters

This contract ensures that the Health Service Executive has access to reliable biochemistry services and laboratory equipment for four major hospitals in the South-East region of Ireland.

This contract matters because it:

• Supports Healthcare Services: Provides biochemistry services at UHW, SLK, TippUH and WGH
• Significant Value: €40,000,000.00 awarded value
• Laboratory Equipment: Hospital laboratory equipment and related proprietary consumables/services
• Balanced Evaluation: 60% quality, 40% cost
• Competition: 4 tenders received (submitted electronically)
• No Subcontracting: No subcontracting declared
• Regional Coverage: Services for four hospitals in the South-East region

Contract Timeline

• Contract concluded: 04 August 2026
• Notice published: 18 September 2026 (OJ S 181/2026)
• Notice dispatch date: 16 September 2026

Contract Overview

Health Service Executive (HSE) conducted an open procedure under the standard regime, governed by EU Directive 2014/24/EU.

Key features include:

• One lot: LOT-0001 (Lot F)
• Estimated value: €40,000,000.00
• Awarded value: €40,000,000.00
• Framework type: No framework agreement
• Evaluation: Quality (60%) and Cost (40%)
• Winner: Roche Diagnostics Limited (large enterprise)
• Subcontracting: No
• No EU funding
• Covered by GPA: Yes
• Strategic procurement: No strategic procurement

Key Contract Details

• Main classification: 33114000 Spectroscopy devices
• Additional classification: 33124100 Diagnostic devices; 33124110 Diagnostic systems; 33124131 Reagent strips; 33152000 Incubators; 33694000 Diagnostic agents; 33696000 Reagents and contrast media; 33696100 Blood-grouping reagents; 33696200 Blood-testing reagents; 33696300 Chemical reagents; 33696500 Laboratory reagents; 33696600 Reagents for electrophoresis; 33696700 Urological reagents; 33790000 Laboratory, hygienic or pharmaceutical glassware; 33793000 Laboratory glassware; 33916000 Autopsy saw blades or accessories; 33916100 Autopsy saws; 33922000 Cadaver transport bags; 33950000 Clinical forensics equipment and supplies; 38000000 Laboratory, optical and precision equipments (excl. glasses); 38311210 Calibration weights; 38437000 Laboratory pipettes and accessories; 38437120 Pipette stands; 38510000 Microscopes; 38950000 Polymerase Chain Reaction (PCR) equipment; 38951000 Real-time PCR equipment; 39180000 Laboratory furniture; 39181000 Laboratory benching; 42122500 Laboratory pumps and accessories; 42931100 Laboratory centrifuges and accessories; 45331231 Installation work of refrigeration equipment; 50433000 Calibration services; 71900000 Laboratory services; 85200000 Veterinary services
• Place of performance: South-East, Ireland (NUTS: IE052)
• Procedure identifier: 3971d044-26a7-42f7-b108-fedd51e11058
• Type of procedure: Open
• Legal basis: Directive 2014/24/EU
• Review body: The High Court of Ireland

Lot Structure

Lot F – Hospital Laboratory Equipment and Related Proprietary Consumables/Services

• Title: Lot F - Hospital Laboratory Equipment and Related Proprietary Consumables/Services
• Description: Provision of Biochemistry Services at UHW, SLK, TippUH and WGH; see published ITT for a description of the requirement
• Internal identifier: 5
• Estimated value: €40,000,000.00
• Awarded value: €40,000,000.00
• Winner: Roche Diagnostics Limited
• Tenders received: 4 (submitted electronically)
• Contract concluded: 04 August 2026
• Contract identifier: 458313

Lot Summary Table

Lot	Title	Value (€)	Winner	Tenders
1	Lot F - Hospital Laboratory Equipment and Related Proprietary Consumables/Services	40,000,000.00	Roche Diagnostics Limited	4
Total		40,000,000.00

Scope of Supply

The contract covers the following supplies and services:

• Biochemistry Services: Provision of biochemistry services at UHW, SLK, TippUH and WGH
• Hospital Laboratory Equipment: Laboratory equipment and related proprietary consumables/services
• Spectroscopy Devices: Spectroscopy devices under CPV 33114000
• Diagnostic Devices and Systems: Diagnostic devices, systems and reagent strips
• Reagents: Diagnostic agents, reagents and contrast media, blood-grouping, blood-testing, chemical, laboratory, electrophoresis and urological reagents
• Laboratory Equipment and Accessories: Incubators, laboratory glassware, pipettes, microscopes, PCR equipment, laboratory furniture, pumps and centrifuges
• Services: Calibration services, laboratory services, installation work of refrigeration equipment

Special Procurement Conditions

• No Framework Agreement: No framework agreement
• No Subcontracting: No subcontracting declared by winner
• No Strategic Procurement: No strategic objectives specified
• Quality and Cost: Quality is 60% of award criteria; cost is 40% of award criteria
• Electronic Submission: Tenders submitted electronically

About the Contracting Authority

Health Service Executive (HSE) is a body governed by public law operating in the health sector in Ireland.

• Legal type: Body governed by public law
• Activity: Health
• Registration number: 00000
• Location: Kildare, Ireland (NUTS: IE062)
• Address: Oak House, Millennium Park, Naas, Co. Kildare
• Email: procurement.helpdesk@hse.ie
• Telephone: 051870612
• Internet address: https://www.hse.ie

About the Winning Supplier

Roche Diagnostics Limited is a large enterprise based in Burgess Hill, West Sussex, United Kingdom, specialising in diagnostics and laboratory solutions.

• Size: Large enterprise
• Registration number: 00000
• Location: Burgess Hill, West Sussex, United Kingdom
• Address: Charles Avenue, Burgess Hill, West Sussex, RH15 9RY
• Email: burgesshill.bids@roche.com
• Subcontracting: No

Evaluation Criteria

The lot uses the following evaluation criteria:

• Quality (60%): Quality is 60% of Award Criteria
• Cost (40%): Cost is 40% of the Award Criteria
• Method: Please see tender documents

Procurement Analysis

• Procedure: Open procedure under the standard regime, governed by EU Directive 2014/24/EU
• Competition: 4 tenders received (submitted electronically)
• Subcontracting: No subcontracting declared
• No EU funding: The procurement was not financed with EU funds
• No framework agreement: No framework agreement
• No dynamic purchasing system used
• Strategic procurement: No strategic procurement
• Review body: The High Court of Ireland
• Call for competition terminated: The call for competition has been terminated (contract awarded)

Additional Procurement Facts

• The contract is covered by the WTO's Government Procurement Agreement (GPA)
• No EU funds were used for this procurement
• The estimated value is €40,000,000.00
• The awarded value is €40,000,000.00
• The procurement is divided into one lot (Lot F)
• Quality (60%) and Cost (40%) are the evaluation criteria
• Four tenders were received (submitted electronically)
• The winner is a large enterprise
• No subcontracting was declared
• The contract was concluded on 04 August 2026
• Services are provided at UHW, SLK, TippUH and WGH

Market & Industry Perspective

The Irish public sector laboratory diagnostics market features a mix of large international diagnostics companies and specialised suppliers. Biochemistry services and laboratory equipment are essential for diagnostic testing in hospitals.

Key trends in this market include:

• Balanced evaluation: 60% quality, 40% cost
• Large providers: Dominance of large diagnostics companies
• Comprehensive scope: Equipment, reagents, consumables and services
• Proprietary consumables: Related proprietary consumables/services
• Regional hospital coverage: Services for four hospitals
• No framework agreement: Direct contract award

Economic Significance

At €40,000,000.00, this contract represents a significant investment in biochemistry services and laboratory equipment for the Health Service Executive. The contract will:

• Support Healthcare Services: Provide biochemistry services at UHW, SLK, TippUH and WGH
• Support Large Enterprise: Roche Diagnostics Limited is a large diagnostics company
• Ensure Diagnostic Capability: Provide laboratory equipment and related consumables
• Enable Clinical Excellence: Support diagnostic testing in four hospitals
• Support Patient Care: Facilitate timely and accurate biochemistry testing
• Regional Coverage: Services across the South-East region

Future Procurement Opportunities

With this contract now in place, future opportunities include:

• Re-tender: Expected after the contract period
• Related Supplies and Services: Additional laboratory equipment, reagents and consumables
• Subcontracting: Potential opportunities with Roche Diagnostics Limited
• Other HSE Projects: Similar biochemistry services procurement opportunities
• Other Irish Hospitals: Similar laboratory diagnostics procurements

Opportunities for Suppliers

While this contract is awarded, opportunities remain for laboratory diagnostics suppliers:

• Re-tender: Prepare for future procurement cycles
• Subcontracting: Potential opportunities with Roche Diagnostics Limited
• Related Supplies and Services: Other laboratory equipment, reagents and consumables
• Other Irish Hospitals: Similar biochemistry services procurements

What Businesses Should Watch

• Health Service Executive's future procurement notices
• Other Irish hospital laboratory diagnostics tenders
• Biochemistry services and laboratory equipment market trends
• Changes to Irish procurement regulations
• Diagnostics and reagent supply requirements

IrelandTenders.com Procurement Intelligence

This biochemistry services contract is a notable example of Irish public sector procurement. Several features stand out:

• Scale: €40M awarded value
• Balanced evaluation: 60% quality, 40% cost
• Large winner: Roche Diagnostics Limited
• One lot: Lot F – Hospital Laboratory Equipment and Related Proprietary Consumables/Services
• Competition: 4 tenders received
• Regional coverage: UHW, SLK, TippUH and WGH
• Comprehensive scope: Equipment, reagents, consumables and services

For suppliers, this procurement highlights the importance of:

• Quality: 60% quality-based evaluation
• Competitive pricing: 40% cost-based evaluation
• Biochemistry and laboratory expertise: Ability to supply laboratory equipment, reagents and consumables
• Public sector experience: Understanding of Irish health service requirements
• Scale capability: Ability to serve multiple hospitals
• Proprietary consumables: Ability to supply related proprietary consumables and services

Supplier Takeaways

• Ensure high quality – 60% of evaluation is quality-based
• Offer competitive pricing – 40% of evaluation is cost-based
• Demonstrate biochemistry and laboratory expertise
• Showcase laboratory equipment, reagent and consumable supply capability
• Develop public sector experience with Irish health services
• Demonstrate scale capability for multi-hospital service delivery
• Monitor HSE and Irish hospital procurement opportunities

Key Takeaways

• Health Service Executive (HSE) awarded a €40,000,000.00 biochemistry services contract to Roche Diagnostics Limited
• One lot: Lot F – Hospital Laboratory Equipment and Related Proprietary Consumables/Services
• Evaluation: Quality (60%) and Cost (40%)
• 4 tenders received (submitted electronically)
• Winner is a large enterprise
• No subcontracting declared
• No EU funding
• Covered by GPA: Yes
• No framework agreement
• Services for UHW, SLK, TippUH and WGH
• Contract concluded on 04 August 2026

Conclusion

This biochemistry services contract ensures that the Health Service Executive has access to reliable laboratory equipment and related proprietary consumables/services for four major hospitals in the South-East region of Ireland. By awarding the contract to Roche Diagnostics Limited, the HSE secures a reliable large enterprise supplier with the scale and capability to deliver comprehensive biochemistry services.

The 60% quality and 40% cost evaluation reflects the balanced nature of laboratory diagnostics procurement, where both quality and cost are important differentiators among qualified suppliers. The comprehensive scope of the contract, covering equipment, reagents, consumables and services, reflects the integrated nature of biochemistry service delivery.

For suppliers, this procurement highlights the importance of quality, competitive pricing, biochemistry and laboratory expertise, public sector experience, scale capability, and proprietary consumables in winning Irish public sector laboratory diagnostics contracts.

Frequently Asked Questions

Q: What is the Health Service Executive (HSE)?

Ans: A body governed by public law operating in the health sector in Ireland, responsible for public health services.

Q: What is the value of the contract?

Ans: Awarded value €40,000,000.00.

Q: Who is the winner?

Ans: Roche Diagnostics Limited, a large enterprise based in Burgess Hill, West Sussex, United Kingdom.

Q: What supplies and services are covered?

Ans: Provision of Biochemistry Services at UHW, SLK, TippUH and WGH, including hospital laboratory equipment and related proprietary consumables/services under Lot F.

Q: What were the evaluation criteria?

Ans: Quality (60%) and Cost (40%).

Q: How many tenders were received?

Ans: Four tenders (submitted electronically).

Q: Is this contract funded by the EU?

Ans: No, the procurement is not financed with EU funds.

Q: What is the review body?

Ans: The High Court of Ireland.

Q: What is the lot structure?

Ans: One lot – LOT-0001 (Lot F – Hospital Laboratory Equipment and Related Proprietary Consumables/Services).

Q: Is subcontracting allowed?

Ans: No subcontracting was declared by the winner.

Q: Which hospitals are covered?

Ans: University Hospital Waterford (UHW), St. Luke's General Hospital Kilkenny (SLK), Tipperary University Hospital (TippUH) and Wexford General Hospital (WGH).

Q: Is there a framework agreement?

Ans: No, there is no framework agreement.

Source: EU Official Journal, Contract Award Notice 645092-2026, OJ S 181/2026, published 18 September 2026.

```